Everolimus (EVE) vs. Mycophenolate (MMF) De Novo After Heart Transplantation (HTx): Does It Matter for Long Term Outcomes?

Autor:	Luciano Potena, Francesco Grigioni, Claudio Rapezzi, Gaia Magnani, L. Borgese, P. Prestinenzi, M. Malossi, M. Sabatino, V. Manfredini, Francesco Barberini, Marco Masetti
Rok vydání:	2015
Předmět:	Pulmonary and Respiratory Medicine Heart transplantation Transplantation medicine.medical_specialty Everolimus business.industry medicine.medical_treatment Urology Mycophenolate Long term outcomes Medicine Surgery Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	The Journal of Heart and Lung Transplantation. 34:S133
ISSN:	1053-2498
DOI:	10.1016/j.healun.2015.01.356
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9cac87d935cb24ac69d7d0979ec5ec12 https://doi.org/10.1016/j.healun.2015.01.356 Zobrazit plný text záznamu